Health Economic Evaluations of Hemochromatosis Screening and Treatment: A Systematic Review.

Malvina HoxhaVisar MalajBruno Zappacosta

Published in: PharmacoEconomics - open (2024)

Economic studies on either the screening, or treatment strategy for HH patients should be performed in more countries. We suggest that cost-effectiveness studies on the role of deferasirox in HH should be carried out as an alternative therapy to phlebotomy.

Keyphrases

end stage renal disease
healthcare
public health
chronic kidney disease
newly diagnosed
mental health
peritoneal dialysis
prognostic factors
patient reported outcomes
replacement therapy
social media
cell therapy
smoking cessation
health promotion